North America Leads the Mesenchymal Stem Cell MSC Therapy Market...

Ajouter une nouvelle offre d'emploi Health

2026-09-23 09:30:55 - Traduire -

North America Leads the Mesenchymal Stem Cell MSC Therapy Market Amid Strong R&D Investment

North America has established itself as the dominant region in the global Mesenchymal Stem Cell MSC Therapy Market, driven by robust healthcare infrastructure, significant investment in regenerative medicine research, and the presence of leading biotechnology companies. The region accounted for a substantial share in 2024, valued at approximately USD 1.25 billion, and is projected to reach USD...

0 Commentaires 0 Parts 3 Vue 0 Aperçu